Drugs Approved for Stomach (Gastric) Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for stomach (gastric) cancer. The list includes generic and brand names. This page also lists common drug combinations used in stomach (gastric) cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in stomach (gastric) cancer that are not listed here.
Drugs Approved for Stomach (Gastric) Cancer
- Capecitabine
- Cyramza (Ramucirumab)
- Docetaxel
- Doxorubicin Hydrochloride
- Enhertu (Fam-Trastuzumab Deruxtecan-nxki)
- 5-FU (Fluorouracil Injection)
- Fam-Trastuzumab Deruxtecan-nxki
- Fluorouracil Injection
- Herceptin (Trastuzumab)
- Keytruda (Pembrolizumab)
- Lonsurf (Trifluridine and Tipiracil Hydrochloride)
- Mitomycin
- Nivolumab
- Nivolumab and Hyaluronidase-nvhy
- Opdivo (Nivolumab)
- Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
- Pembrolizumab
- Ramucirumab
- Taxotere (Docetaxel)
- Tevimbra (Tislelizumab-jsgr)
- Tislelizumab-jsgr
- Trastuzumab
- Trifluridine and Tipiracil Hydrochloride
- Vyloy (Zolbetuximab-clzb)
- Xeloda (Capecitabine)
- Zolbetuximab-clzb
Drug Combinations Used in Stomach (Gastric) Cancer
Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors